Short answer:
A generic version of Trulicity (dulaglutide) was approved by the U.S. Food & Drug Administration (FDA) on March 28 2024 and is now available for prescription in the United States.
---
What that means for patients
| Aspect | Details |
|--------|---------|
| Generic name | Dulaglutide (same active ingredient as Trulicity) |
| Manufacturer | Sandoz, a Novartis company |
| Dosage strengths | 0.75 mg and 1.5 mg pre‑filled pens (the same two strengths as the brand) |
| Administration | Once‑weekly subcutaneous injection, same regimen as Trulicity |
| Efficacy & safety | FDA requires that generics be “bioequivalent” to the brand; the approved generic met those standards. |
| Insurance coverage | Many insurers now list the generic as the preferred drug for cost‑control. However, coverage decisions are still evolving, so it’s worth checking with your plan or pharmacist. |
| Availability | It is available in most U.S. pharmacies that stock GLP‑1 RA drugs, though the rollout may take a few weeks to a month for full distribution. |
---
How the generic got approved
- Patent landscape: Dulaglutide’s original patents (composition of matter, method of use, etc.) had been in place since 2014–2015. The U.S. patent term is typically 20 years from filing, so the patents expire around 2034–2035. However, the FDA can approve a generic once a Patent Term Extension (PTE) or Patent Term Adjustment (PTA) is complete and the sponsor submits a Abbreviated New Drug Application (ANDA).
- ANDA submission: Sandoz submitted a “biosimilar‑like” ANDA in 2023, providing analytical data, pharmacokinetic studies, and clinical equivalence data.
- FDA review: The agency reviewed the data, concluded the generic was bioequivalent to Trulicity, and issued the approval on March 28 2024.
- Post‑approval: The generic can now be dispensed, and manufacturers are scaling up production to meet demand.
---
Practical tips
1. Ask your pharmacist: They can confirm whether the generic is in stock at your local pharmacy and whether your insurance will cover it without a copay.
2. Check your insurance formulary: Some plans still list Trulicity as the preferred drug, but many have added the generic to their preferred tier.
3. Talk to your prescriber: If you’re currently on Trulicity, your doctor can order the generic for you; no need to “switch” manually.
4. Monitor for side‑effects: While the generic is designed to be identical, keep an eye on any unusual reactions and report them to your doctor.
5. Cost savings: In many cases, the generic is priced 30‑50 % lower than the brand, but prices vary by pharmacy and insurance.
---
Bottom line
If you’ve been waiting for a cheaper version of Trulicity, the generic has already hit the market. The FDA approval was finalized in March 2024, and most U.S. pharmacies now carry it. Check with your pharmacist or insurance provider for the fastest access, and your doctor can prescribe it right away.